Treatment Outcomes of Epithelial Ovarian Cancer A Longitudinal Study (original) (raw)
Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia
Absarul Haque
2022
View PDFchevron_right
Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy
Amita Maheshwari
Indian journal of cancer
View PDFchevron_right
Chemotherapeutic Regimens and Chemotherapy-Free Intervals Influence the Survival of Patients with Recurrent Advanced Epithelial Ovarian Carcinoma: A Retrospective Population-Based Study
Wen-fang Cheng
International Journal of Environmental Research and Public Health
View PDFchevron_right
The Significance of Combination Chemotherapy in Epithelial Ovarian Cancer
Colleen McGahan
International Journal of Gynecologic Cancer, 2014
View PDFchevron_right
Epithelial Ovarian Cancer-an Audit of Patients Treated Over 15 Years
Anu Tiwari
Indian Journal of Medical and Paediatric Oncology, 2006
View PDFchevron_right
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Munlima Hazarika
Indian Journal of Medical and Paediatric Oncology, 2015
View PDFchevron_right
Management of Ovarian Cancer: Experience of a single Institution
Enas A Elkhouly
Research in Oncology, 2014
View PDFchevron_right
A retrospective study on ovarian cancer with a median follow-up of 36 months at Bejaïa University Hospital
IJAERS Journal
View PDFchevron_right
The predictors of response to neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Ozge Gultekin
Journal of Surgical Oncology, 2011
View PDFchevron_right
Factors Favoring Long Term Survival in Patients with Stage IV Epithelial Ovarian Cancer: An Institutional Research
Fatima Ali
Asian Pacific Journal of Cancer Care
View PDFchevron_right
Survival after recurrence in early-stage high-risk epithelial ovarian cancer: A Gynecologic Oncology Group study
Thomas Herzog
Gynecologic Oncology, 2010
View PDFchevron_right
Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin–paclitaxel chemotherapy
sonia cipriani
Gynecologic Oncology, 2005
View PDFchevron_right
Neoadjuvant Chemotherapy Reduces the Treatment-free Interval After First-line Treatment in Patients With Advanced Ovarian Cancer
Svend Engelholm
Anticancer Research, 2020
View PDFchevron_right
Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study
Jacob McGee
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018
View PDFchevron_right
Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment
Fiona Kew
Reviews, 1996
View PDFchevron_right
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria
benedetto osunwusi
JCO Global Oncology, 2021
View PDFchevron_right
Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinoma
Eric Raymond
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1997
View PDFchevron_right
Outcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience
Nilesh Sable
South Asian Journal of Cancer, 2016
View PDFchevron_right
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
Michael Fung-Kee-Fung
Current Oncology, 2007
View PDFchevron_right
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))
Valter Torri
British journal of cancer, 1990
View PDFchevron_right
Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer
Daniela Matei
Cancer, 2010
View PDFchevron_right
The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study
Heinz Koelbl
PloS one, 2017
View PDFchevron_right
Neoadjuvant Versus Adjuvant Chemotherapy in Advanced Ovarian Carcinoma ministry of interior, Egypt
Fortune Journals
View PDFchevron_right
Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients
Elona Juozaitytė
BMC cancer, 2006
View PDFchevron_right
Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer
Kristen Starbuck
PLoS ONE, 2018
View PDFchevron_right
Treatment Experience and Predictive Factors Associated with Response in Platinum-Resistant Recurrent Ovarian Cancer: A Retrospective Single-Institution Study
Valeria Mocanu
2021
View PDFchevron_right